TrialThe oncologist2016

Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.

Anthony J Olszanski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.